Pharmacogenomics in clinical practice to prevent risperidone-induced hyperprolactinemia in autism spectrum disorder
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics in clinical practice to prevent risperidone-induced hyperprolactinemia in autism spectrum disorder
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 23, Issue 8, Pages 493-503
Publisher
Future Medicine Ltd
Online
2022-04-28
DOI
10.2217/pgs-2022-0016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone
- (2021) Jinjun Lu et al. BMC Psychiatry
- Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone
- (2021) Yaowaluck Hongkaew et al. Scientific Reports
- Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings
- (2021) Chonlaphat Sukasem et al. Drug Metabolism and Pharmacokinetics
- Resolving discordant CYP2D6 genotyping results in Thai: platform limitations and novel haplotypes
- (2021) Yaowaluck Hongkaew et al. PHARMACOGENOMICS
- Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
- (2021) Paula Soria-Chacartegui et al. Frontiers in Pharmacology
- Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder
- (2021) Yaowaluck Hongkaew et al. Frontiers in Pharmacology
- A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
- (2021) Chiraphat Kloypan et al. Pharmaceuticals
- Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia
- (2020) Lisanne M. Geers et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD)
- (2020) Ann Genovese et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics
- (2019) Jose de Leon NEUROPHARMACOLOGY
- Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial
- (2019) C. Lindsay DeVane et al. PHARMACOTHERAPY
- Clinical and Laboratory Characteristics of Hyperprolactinemia in Children and Adolescents: National Survey
- (2019) Erdal Eren et al. Journal of Clinical Research in Pediatric Endocrinology
- Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
- (2019) Susan L. Hyman et al. PEDIATRICS
- Classics in Chemical Neuroscience: Risperidone
- (2018) Trevor C. Chopko et al. ACS Chemical Neuroscience
- Pharmacogenetics of Risperidone-Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder
- (2018) Chonlaphat Sukasem et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- CYP2D6 genotype analysis of a Thai population: platform comparison
- (2018) Monpat Chamnanphon et al. PHARMACOGENOMICS
- UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder
- (2018) Yaowaluck Hongkaew et al. PHARMACOGENOMICS JOURNAL
- Autism spectrum disorder
- (2018) Catherine Lord et al. LANCET
- Hyperprolactinemia in Children with Subclinical Hypothyroidism
- (2017) Neera Sharma et al. Journal of Clinical Research in Pediatric Endocrinology
- Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders
- (2016) Natchaya Vanwong et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders
- (2016) Chonlaphat Sukasem et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
- (2016) Amilton Dos Santos-Júnior et al. International Journal of Endocrinology
- Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients
- (2016) Sadeep Medhasi et al. Frontiers in Pharmacology
- In vivoassessment of the metabolic activity of CYP2D6 diplotypes and alleles
- (2015) Daniel L. Hertz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort
- (2015) Frederik Vandenberghe et al. CLINICAL PHARMACOKINETICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
- (2015) JK Hicks et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol
- (2015) Patteet Lisbeth et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk factors for autism spectrum disorder in the Thai population
- (2015) Chusana Khaiman et al. EUROPEAN JOURNAL OF PEDIATRICS
- Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects
- (2015) Amilton dos Santos Júnior et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Comparative Pharmacology of Risperidone and Paliperidone
- (2015) Maria Corena-McLeod Drugs in research & development
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
- (2014) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
- (2013) E L Nurmi et al. Translational Psychiatry
- Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
- (2011) Roberto Canitano Neuropsychiatric Disease and Treatment
- Long-acting risperidone: a review of its role in the treatment of bipolar disorder
- (2009) David E. Kemp et al. ADVANCES IN THERAPY
- A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms
- (2009) P Gassó et al. PHARMACOGENOMICS JOURNAL
- Effect of Rifampin, an Inducer of CYP3A and P-glycoprotein, on the Pharmacokinetics of Risperidone
- (2007) Kyoung-Ah Kim et al. JOURNAL OF CLINICAL PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now